0

Journal Articles

in Osteoporosis/Metabolic Bone Disease
 1-20 of 54 Articles
Health Agencies Update |  July 25, 2012
HIV and Bone Mass
Bridget M. Kuehn
JAMA. 2012;308(4):331. doi:10.1001/jama.2012.8437.
Viewpoint |  June 27, 2012
Bone Density Screening Intervals for Osteoporosis:  One Size Does Not Fit All
Elaine W. Yu, MD; Joel S. Finkelstein, MD
JAMA. 2012;307(24):2591-2592. doi:10.1001/jama.2012.6977.
Research Letters |  January 18, 2012 FREE
Screening for Osteoporosis in Men Receiving Androgen Deprivation Therapy
Shabbir M. H. Alibhai, MD, MSc; Lingsong Yun, MSc; Angela M. Cheung, MD, PhD; et al.
JAMA. 2012;307(3):255-256. doi:10.1001/jama.2011.2022.
Editorial |  February 23, 2011
Is Nitroglycerin a Novel and Inexpensive Treatment for Osteoporosis?
Sundeep Khosla, MD
JAMA. 2011;305(8):826-827. doi:10.1001/jama.2011.191.
Preliminary Communication |  February 23, 2011 FREE
Effect of Nitroglycerin Ointment on Bone Density and Strength in Postmenopausal Women:  A Randomized Trial
Sophie A. Jamal, MD, PhD; Celeste J. Hamilton, MSc; Richard Eastell, MD; et al.
JAMA. 2011;305(8):800-807. doi:10.1001/jama.2011.176.
INCLUDES: , Supplemental Content
Commentary |  November 10, 2010
Desktop Medicine
Jason Karlawish, MD
JAMA. 2010;304(18):2061-2062. doi:10.1001/jama.2010.1624.
Clinical Crossroads Update |  November 11, 2009
Update: A 55-Year-Old Woman With Osteopenia
Anna A. Mattson-DiCecca, BA; Eileen E. Reynolds, MD; Jen R. Cummings, MD
JAMA. 2009;302(18):2023-2024. doi:10.1001/jama.2009.1647.
Health Agencies Update |  December 24, 2008
Osteoporosis Drugs
JAMA. 2008;300(24):2846. doi:10.1001/jama.2008.858.
Commentary |  March 26, 2008
Osteoporosis and Fractures:  Missing the Bridge?
Angela M. Cheung, MD, PhD; Allan S. Detsky, MD, PhD
JAMA. 2008;299(12):1468-1470. doi:10.1001/jama.299.12.1468.
Original Contribution |  March 19, 2008 FREE
Large-Scale Analysis of Association Between LRP5 and LRP6 Variants and Osteoporosis
Joyce B. J. van Meurs, PhD; Thomas A. Trikalinos, MD; Stuart H. Ralston, MD; et al.
JAMA. 2008;299(11):1277-1290. doi:10.1001/jama.299.11.1277.
INCLUDES: , Supplemental Content
Original Contribution |  August 08, 2007 FREE
Cost-effectiveness of Bone Densitometry Followed by Treatment of Osteoporosis in Older Men
John T. Schousboe, MD, MS; Brent C. Taylor, PhD, MPH; Howard A. Fink, MD, MPH; et al.
JAMA. 2007;298(6):629-637. doi:10.1001/jama.298.6.629.
Editorial |  December 27, 2006
Ten vs Five Years of Bisphosphonate Treatment for Postmenopausal Osteoporosis:  Enough of a Good Thing
Cathleen S. Colón-Emeric, MD, MHSc
JAMA. 2006;296(24):2968-2969. doi:10.1001/jama.296.24.2968.
JAMA Patient Page |  December 06, 2006 FREE
Osteopenia and Preventing Fractures
Janet M. Torpy, MD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2006;296(21):2644. doi:10.1001/jama.296.21.2644.
INCLUDES: , Supplemental Content
Clinical Crossroads |  December 06, 2006
A 55-Year-Old Woman With Osteopenia
Steven R. Cummings, MD
JAMA. 2006;296(21):2601-2610. doi:10.1001/jama.296.21.2601.
INCLUDES: CME
Medical News and Perspectives |  June 28, 2006
Reports of Adverse Events From Bone Drugs Prompt Caution
JAMA. 2006;295(24):2833-2838. doi:10.1001/jama.295.24.2833.
The World in Medicine |  April 19, 2006
Bone-Sparing Antibiotic?
JAMA. 2006;295(15):1763. doi:10.1001/jama.295.15.1763-c.
Grand Rounds |  September 14, 2005
Tumor-Induced Osteomalacia
Suzanne M. Jan de Beur, MD
JAMA. 2005;294(10):1260-1267. doi:10.1001/jama.294.10.1260.
INCLUDES: CME
Lab, Field, and Clinic |  July 06, 2005
Evidence-Based Guidelines Needed for Osteoporosis Screening and Treatment
JAMA. 2005;294(1):34. doi:10.1001/jama.294.1.34.
Medical News and Perspectives |  May 25, 2005
Better Osteoporosis Management a Priority
JAMA. 2005;293(20):2453-2462. doi:10.1001/jama.293.20.2453.
Medical News and Perspectives |  May 25, 2005
Longer-lasting Osteoporosis Drugs Sought
JAMA. 2005;293(20):2458. doi:10.1001/jama.293.20.2458.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Invited Commentary  |  February 4, 2013
Are Calcium Supplements Harmful to Cardiovascular Disease?:  Comment on “ Dietary and Supplemental Calcium Intake and Cardiovascular Diseases Mortality: The National Institutes of Health–AARP Diet and Health Study”
Susanna C. Larsson, PhD
JAMA Ophthalmology
Small Case Series  |  Feb 2013
Squamous Metaplasia of the Conjunctiva:  A Previously Unrecognized Adverse Effect of Risedronate Sodium
Ivayla I. Geneva, BA; Ralph C. Eagle, MD; Ann Barker-Griffith, MD, FRCSC; et al.
JAMA Internal Medicine
Editor's Correspondence  |  Jan 14, 2013
Are Bisphosphonates Associated With an Increased Risk of Atypical Femoral Fractures as a Class?
Michael Pazianas, MD
JAMA Internal Medicine
Original Investigation  |  June 25, 2012
Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use
Raphael P. H. Meier, MD; Thomas V. Perneger, MD; Richard Stern, MD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems